Synthesis, radiolabeling and in vivo tissue distribution of an anti-oestrogen glucuronide compound, 99mTc-TOR-G

Anticancer Research

Volumn 30, Issue 4, 2010, Pages 1243-1249

  Biber Muftuler, F Z ^a   Unak, P ^a   Yolcular, S ^a   Yurt Kilcar, A ^a   Ichedef, C ^a   Enginar, H ^b   Sakarya, S ^c  

^a EGE UNIVERSITY   (Turkey)

^b AFYON KOCATEPE UNIVERSITY   (Turkey)

^c ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

99mTc TOR G; Diethylenetriamine pentaacetic acid DTPA; Receptor saturated study of toremifene glucuronide labelled with 99mTc 99mTc Rec TOR G; Toremifene; Toremifene glucuronide labelled with 99mTc

Indexed keywords

FAT; GLUCURONIC ACID; GLUCURONOSYLTRANSFERASE; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TOREMIFENE; TOREMIFENE GLUCURONIC ACID TC 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL LINE; CELL STRAIN; CELL STRAIN HUTU 80; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG GLUCURONIDATION; DRUG HALF LIFE; DRUG SYNTHESIS; DRUG UPTAKE; ENZYME MECHANISM; ENZYME PURIFICATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VIVO STUDY; ISOTOPE LABELING; MICROSOME; NONHUMAN; PAPER ELECTROPHORESIS; PARTITION COEFFICIENT; PRIORITY JOURNAL; RADIOACTIVITY; RADIOCHROMATOGRAPHY; RAT; THIN LAYER CHROMATOGRAPHY; TISSUE DISTRIBUTION;

ANIMALS; CELL LINE, TUMOR; DUODENAL NEOPLASMS; ESTROGEN RECEPTOR MODULATORS; FEMALE; GLUCURONIC ACID; HUMANS; ISOTOPE LABELING; MUSCLES; ORGANOTECHNETIUM COMPOUNDS; OVARY; PENTETIC ACID; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TECHNETIUM COMPOUNDS; TISSUE DISTRIBUTION; TOREMIFENE;

EID: 77953764025     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Musa MA, Khan MOF and Cooperwood JS: Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs), Curr Med Chem 14: 1249-1261, 2007.
2. Harvey HA, Kimura M and Hajba A: Toremifene: an evaluation of its safety profile. Breast J 15: 142-157, 2006.
3. Pukkala E, Kyyrönen P, Sankila R and Holli K: Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population-based case-control study. Int J Cancer 100: 337-341, 2002.
4. Sperker B, Backman JT and Kroemer HK: The role of beta-glucuronidase in drug disposition and drug targeting in humans. J Clin Pharmacol 33: 18-31, 1997.
5. Sperker B, Werner U, Murdter TE, Tekkaya C, Fritz P, Wacke R, Adam U, Gerken M, Drewelow B and Kroemer HK: Expression and function of beta-glucuronidase in pancreatic cancer: potential role in drug targeting. Naunyn-Schmiedebergs Archieves of Pharmacology 362: 110-115, 2000.
6. Houba PHJ, Leenders RGG, Boven E, Scheeren JW, Pinedo HM and Haisma HJ: Characterization of novel anthracycline prodrugs activated by human β-glucuronidase for use in antibody-directed enzyme prodrug therapy, Biochem Pharmacol 9: 455-463, 1996.
7. Kamal A, Tekumalla V, Raju P, Naidu VGM, Diwan PV and Sistla R: Pyrrolo[2,1-c][1,4]benzodiazepine-β-glucuronide prodrugs with a potential for selective therapy of solid tumors by PMT and ADEPT strategies, Bioorg Med Chem Lett 18: 3769-3773, 2008.
8. 99mTc radiopharmaceuticals. Ann Nucl Med 16: 79-93, 2002.
9. Jurisson SS and Lydon JD: Potential technetium small molecule radiopharmaceuticals. Chem Rev 99: 2205-2218, 1999.
10. Katzenellenbogen JA: Designing steroid receptor-based radiotracers to image breast and prostate rumour. J Nucl Med 36: 8S-13S, 1995.
11. Me'ndez-Rojaz MA, Kharisov BI and Tsivadze AY: Recent advances on technetium complexes: coordination chemistry and medical applications. J Coord Chem 59: 1-63, 2006.
12. 11C-toremifene in rats bearing dmba-induced mammary carcinoma. Pharmacol Toxicol 64: 373-377, 1989. (Pubitemid 19096980)
13. Spila H, Kangas L, Vuorilehto L, Kalapudas A, Eloranta M, Sodervall M, Toivola R and Anttila M: Metabolism of toremifene in the rat. J Steroid Biochem 36: 211-215, 1990.
14. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
15. Alkharfy KM and Frye RF: Sensitive liquid chromatographic method using fluorescence detection for the determination of estradiol 3- and 17-glucuronides in rat and human liver microsomal incubations: formation kinetics. J Chromatogr B Analyt Technol Biomed Life Sci 1: 33-38, 2002.
16. Stevenson DE: Optimisation of UDP-glucuronyl transferase-catalysed synthesis of testosterone-β-D-glucuronide by inhibition of contaminating β-glucuronidase. Biotechnol Techn 13: 17-21, 1999.
17. Stevenson DE and Hubl U: Optimization of β-glucuronide synthesis using UDP-glucuronyl transferase. Enzyme and Microbial Tech 24: 388-396, 1999.
18. Mihailescu R, Aboul-Enein HY and Efstatide MD: Identification of tamoxifen and metabolites in human male urine by GC/MS. Biomed Chromatogr 14: 180-183, 2000.
19. 99mTc-TOR-DTPA). Cancer Biother Radiopharmac 24: 707-716, 2009.
20. Unak T, Avcibaşi U, Yildirim Y and Cetinkaya B: Attempts to develop a new nuclear measurement technique of β-glucuronidase levels in biological samples. Czech J Phys 53: A797-A802, 2003.
21. Yin HQ, Bennett G and Jones JP: Mechanistic studies of uridine-diphosphate glucuronosyltransferase. Chemicobiol Interact 90 1: 47-58, 1994
22. De Gregorio MW, Wurz GT, Taras TL, Erkkola RU and Halonen KH: Pharmacokinetics of (deaminohydroxy) toremifene in humans: A new, selective estrogen-receptor modulator. Eur J Pharm Sci 56: 469-475, 2000.
23. Delpassand SE, Yang JD, Wallace S, Chenf A, Quadri MS, Price J, Joubert A, Inoue T and Podoloff AD: Synthesis, biodistribution and estrogen receptor scintigraphy of indium-111-diethylenetriamine pentaacetic acid-tamoxifen analogue. J Pharm Sci 85: 553-559, 1996.
24. 125I](Z)-3-methoxy-17α-iodovinylestra- 1,3,5(10),6-tetraen-17β-ol. Appl Radiat Isot 54: 227-239, 2001.
25. 131I-labelled estrone derivatives and biodistribution studies on rats. J Radioanal Nucl Chem 264: 535-539, 2005.